Whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer.
By Vijay Kumar MalesuMay 2 2024Reviewed by Lily Ramsey, LLM In a recent study published in the JAMA, a group of researchers determined whether aspirin decreases the risk of invasive cancer events among survivors of breast cancer .
Further research is needed to explore aspirin's potential benefits and mechanisms in cancer therapy, particularly identifying specific patient subgroups who might benefit from its use. Related StoriesThe trial involved 3020 patients but was halted early due to a lack of significant benefits, as the hazard ratio for disease-free survival between the aspirin and placebo groups was 1.27.
At the point of enrollment, the majority of participants had hormone receptor-positive disease, had undergone chemotherapy, and had a median time from diagnosis to enrollment of around 13 months.
Breast Cancer Cancer Adenocarcinoma Adjuvant Therapy Cancer Therapy Hormone Mortality Placebo Receptor Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Aspirin's immune-boosting effects in colorectal cancer revealedStudy reveals that aspirin helps the body’s immune system detect and target cancer cells.
Read more »
The aspirin conundrum: Navigating negative results, age, aging dynamics and equityA new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University's Lombardi Comprehensive Cancer Center.
Read more »
How does aspirin help prevent colorectal cancer development and progression?Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but the mechanisms involved have been unclear. New research has revealed that aspirin may exert these protective effects by boosting certain aspects of the body's immune response against cancer cells. The findings are published in Cancer.
Read more »
An aspirin a day ‘weaponises’ immune system to hunt and destroy bowel cancer cells...Sun Health Explainer: Bowel Cancer
Read more »
Stopping aspirin 1 month after coronary stenting significantly reduces bleeding complications in heart attack patientsWithdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared to patients taking aspirin and ticagrelor combined (also known as dual antiplatelet therapy or DAPT), which is the current...
Read more »
It's worth checking whether local No voters might be turning to YesAN extraordinary tale of how one thing leads to another. I read in The National that Professor Elisa Morgera has become the United Nations Special…
Read more »